Intelligence, benchmarking, and certification for risk and compliance leaders, from the institution setting the standard since 1922.
The year 2017 was marked by pivotal change for AstraZeneca. At that time, the British-Swedish global pharmaceutical and biopharmaceutical company was undergoing a major cultural shift, transforming its Code of Conduct into a Code of Ethics.
Jaclyn Jaeger is a freelance contributor to Compliance Week after working for the company for 15 years. She writes on a wide variety of topics, including ethics and compliance, risk management, legal,... More by Jaclyn Jaeger
We'll send a verification code to %EMAIL%.
